Levonorgestrel News and Research

RSS
Combe announces launch of Preventeza Emergency Contraceptive and campaign

Combe announces launch of Preventeza Emergency Contraceptive and campaign

Researchers identify barriers to emergency contraception access in retail pharmacies

Researchers identify barriers to emergency contraception access in retail pharmacies

Early placement of hormonal IUD does not negatively affect breastfeeding or lactation

Early placement of hormonal IUD does not negatively affect breastfeeding or lactation

Oral contraceptive pills have negative impact on women's quality of life, study shows

Oral contraceptive pills have negative impact on women's quality of life, study shows

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

Clinical trial finds women with heavy periods can be greatly helped by GP-prescribed treatments

Clinical trial finds women with heavy periods can be greatly helped by GP-prescribed treatments

Hormonal contraception may increase susceptibility of women to genital infection

Hormonal contraception may increase susceptibility of women to genital infection

New study provides biological explanation for how DMPA increases risk of HIV infection

New study provides biological explanation for how DMPA increases risk of HIV infection

Mylan releases generic version of Seasonale Tablets in the U.S.

Mylan releases generic version of Seasonale Tablets in the U.S.

Alternative treatment options for uterine fibroids

Alternative treatment options for uterine fibroids

Contraception access: an interview with Pamela Weir, Chief Operating Officer, Medicines360

Contraception access: an interview with Pamela Weir, Chief Operating Officer, Medicines360

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Bayer expands patient assistance program for intrauterine devices

Bayer expands patient assistance program for intrauterine devices

Actavis provides overview of standalone global pharmaceutical development pipeline

Actavis provides overview of standalone global pharmaceutical development pipeline

Study: IUDs, contraceptive implants remain highly effective one year beyond approved duration of use

Study: IUDs, contraceptive implants remain highly effective one year beyond approved duration of use

Study finds unnecessary hysterectomy in 1 out of 5 cases

Study finds unnecessary hysterectomy in 1 out of 5 cases

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Researchers recommend iron supplementation to women with heavy menstrual bleeding

Researchers recommend iron supplementation to women with heavy menstrual bleeding

Survey finds counterfeit and defective emergency contraceptives in Peru

Survey finds counterfeit and defective emergency contraceptives in Peru

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.